Antihypertensive Medication Reduction in Patients with Significant Weight Loss

Rationale for Dose Reduction

Weight loss of 10 kg is associated with an average 6.0 mmHg reduction in systolic BP and 4.6 mmHg reduction in diastolic BP, with the greatest benefit observed in patients already receiving antihypertensive therapy, according to the American Heart Association 1, 2
The American Diabetes Association recommends a target BP of <130/80 mmHg for patients with diabetes, which this patient has achieved with a BP of 104/80 mmHg 3

The American College of Cardiology recommends discontinuing or reducing Metoprolol succinate as the initial step in medication adjustment, as beta-blockers are not indicated as primary antihypertensive agents in the absence of prior MI, active angina, or heart failure with reduced ejection fraction 4, 5
The American Heart Association suggests that beta-blockers have not been shown to reduce mortality as BP-lowering agents when these compelling indications are absent, and provides minimal additional benefit in the context of improved metabolic status and weight loss 3, 4

The American Heart Association recommends rechecking BP in 1-2 weeks after stopping metoprolol, and having the patient perform home BP monitoring during this period 4, 5
The American Diabetes Association recommends maintaining a target BP of <130/80 mmHg given the patient's diabetes history, and rechecking BP monthly for 3 months if stable, then every 3 months if BP remains controlled 3, 5

The American Heart Association recommends continuing to encourage weight maintenance, dietary sodium restriction, regular physical activity, and the DASH diet to sustain BP control, as these interventions will help maintain the BP reduction achieved with weight loss 1, 2, 6